|
|
|
Insider
Information: |
Cannell Thomas R |
Relationship: |
President and CEO, Dir... |
City: |
La Jolla |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
676,268 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$907,742 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
676,268 |
|
|
Total
Value |
$907,742 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-150.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Orexigen Therapeutics, Inc. |
OREX |
EVP, COO, Pres Global ... |
2017-05-31 |
3,882 |
2015-11-30 |
0 |
Premium* |
|
Carisma Therapeutics Inc |
CARM |
President and CEO, Dir... |
2023-03-02 |
672,386 |
2022-02-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CARM |
Carisma Therapeutics Inc |
President and CEO |
|
2023-03-02 |
4 |
OE |
$0.59 |
$356,192 |
D/D |
606,800 |
950,950 |
0 |
- |
|
CARM |
Carisma Therapeutics Inc |
President and CEO |
|
2023-03-02 |
4 |
S |
$0.59 |
$286,155 |
D/D |
(487,487) |
672,386 |
0 |
% |
|
CARM |
Carisma Therapeutics Inc |
President and CEO |
|
2023-02-21 |
4 |
S |
$0.59 |
$31,554 |
D/D |
(53,727) |
553,073 |
0 |
% |
|
CARM |
Carisma Therapeutics Inc |
President and CEO |
|
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
606,800 |
606,800 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
EVP, COO, Pres Global Com Prod |
|
2017-05-31 |
4 |
A |
$1.55 |
$3,284 |
D/D |
2,119 |
3,882 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
EVP, COO, Pres Global Com Prod |
|
2016-11-30 |
4 |
A |
$1.67 |
$486 |
D/D |
291 |
1,763 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
EVP, Chief Commercial Officer |
|
2016-05-31 |
4 |
A |
$0.34 |
$3,275 |
D/D |
9,632 |
14,723 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
EVP, Chief Commercial Officer |
|
2015-11-30 |
4 |
A |
$2.03 |
$10,335 |
D/D |
5,091 |
5,091 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|